SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001513162-20-000137
Filing Date
2020-07-02
Accepted
2020-07-02 17:15:17
Documents
1
Period of Report
2020-07-02
Effectiveness Date
2020-07-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 491717
  Complete submission text file 0001513162-20-000137.txt   492929
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: DEF 14A | Act: 34 | File No.: 001-37492 | Film No.: 201010791
SIC: 2834 Pharmaceutical Preparations